Woman with type 1 diabetes shares the 15-minute habit that helps lower her blood sugarFor a woman managing type one diabetes, brisk walking becomes a key strategy for regulating high blood sugar. During physical activity, the...
28 Aug, 2026, 07.13 PM IST
Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targetsElara has initiated coverage on four pharmaceutical stocks, assigning Buy, Accumulate and Reduce ratings. Alkem Laboratories emerged as its...
28 Aug, 2026, 01.28 PM IST
Convening India's brightest minds: The Bharat Life Sciences Award’s Innovation Summit to spotlight life sciencesIndia sets its sights on becoming a frontrunner in innovation within the life sciences arena. The Bharat Life Sciences Award 2026 aims to h...
27 Aug, 2026, 04.19 PM IST
Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...
27 Aug, 2026, 02.03 PM IST
White House to announce new drug pricing deals with biotechs: ReportThe Trump administration is expected to announce voluntary drug-pricing agreements with midsize biotech companies, requiring discounts for ...
27 Aug, 2026, 07.21 AM IST
USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observationsAurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducte...
24 Aug, 2026, 12.58 PM IST
Eli Lilly launches oral weight-loss pill Foundayo in UKEli Lilly has launched its oral weight management pill Foundayo in the United Kingdom. This new treatment, chemically known as orforglipron...
24 Aug, 2026, 10.29 AM IST
GLP-1 drugs create new market for collagen, protein and beauty products in IndiaThe rising use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with companies developin...
21 Aug, 2026, 08.29 AM IST
Delhi High Court rules in favour of Dr Reddy's Labs in trademark row with RazentaThe Delhi High Court ordered the removal of Razenta Pharmaceuticals' Daplogin trademark. This decision came as the mark was deemed deceptiv...
21 Aug, 2026, 12.03 AM IST
In 2019, research began with users of anti-diabetes treatment medicines, now study shows side effect could be hair lossDiabetes treatment: The researchers said while the study was a rigorous one, based on high quality data from a large representative cohort,...
20 Aug, 2026, 08.21 PM IST
Mankind Pharma inks in-licensing pact with China's Chongqing Chenan BiopharmaceuticalMankind Pharma has secured an exclusive agreement with Chongqing Chenan Biopharmaceutical. This partnership focuses on commercialising two ...
20 Aug, 2026, 01.46 PM IST
Nestle looks to develop new products to serve users of weight-loss drugsNestle is developing specialized products for GLP-1 weight-loss drug users. Artificial intelligence aids in analyzing research and identify...
17 Aug, 2026, 11.45 AM IST
In 2020, Alzheimer’s diagnose process received major breakthrough approval, six years later 7 million patient in U.S. get another big announcement for progressive brain disease treatmentMore than 7 million people in the United States have Alzheimer's, and the number of people aged 65 or older with the disease could exceed ...
14 Aug, 2026, 10.04 PM IST
UK first in Europe to approve Eli Lilly oral weight loss drugBritain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...
11 Aug, 2026, 05.05 PM IST
Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetesBritain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...
11 Aug, 2026, 07.47 AM IST
Novo CEO says setbacks demand faster research, acquisitions as investors fret over pipelineNovo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...
05 Aug, 2026, 02.46 PM IST
Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug adsNovo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers...
24 Jul, 2026, 06.58 PM IST